A Powerful New Tool for Decoding Gene Functions in Mammals and Man
A collaborative project between American and Chinese researchers developed a way to study the function of genes in mice and man by using a moveable genetic element from moths, according to a report in the journal Cell.
"We know how many genes are in the mammalian genome, but that does not tell us how they carry out their jobs," said senior author Tian Xu, Professor and Vice Chair of Genetics at Yale University School of Medicine and a Howard Hughes Medical Institute Investigator. "We have found a way to systematically inactivate genes in the mouse genome so we can understand the functions of these genes."
After sequencing the human and mouse genomes, many scientists have shifted their attention to determining the function of all of those genes. The strategy is to mutate each gene, to observe the consequences, and investigate the molecular mechanisms. In the past two decades, only a small percentage of the genes shared by mice and humans have been analyzed in detail.
Genetic elements, called transposons, move from place to place in the DNA and allow material to be inserted or relocated. Bacteria swap antibiotic-resistance genes with transposons. Scientists have tailored this natural gene shuffling technique to insert genes and to mutate genes in fruit flies and simple organisms to learn the function of individual genes. Transposons have proved to be valuable genetic tools for many organisms, but not for vertebrates and mammals. General application in mouse genetics was limited as they travel at low frequencies to limited locations, and had little capacity to carry DNA fragments. It took Xu's team six years to develop an efficient tool for genetic manipulations in vertebrates and mammals.
Xu and his colleagues at Fudan University in Shanghai, China finally chose a transposon called piggyBac that was originally identified in the cabbage looper moth. They discovered that it was stable and versatile in mouse and human cell lines, providing a new way to genetically manipulate mammalian cells. It also worked in mice even when it carried a couple of extra genes. Xu's team made it easier to see the genes piggyBac associates with by adding a red fluorescent protein and an enzyme that changes the coat color of a white mouse to grey or black. The genes carried by the transposons have been stably inherited and expressed through five generations.
"The transposon acts as a genetic beacon, so researchers can easily track its location without having to sequence the entire genome," said Xu. In their experiments, piggyBac incorporated into many chromosomes in human and mouse cells. PiggyBac can be removed from a mouse lineage by breeding with another mouse that has the enzyme to excise the transposon. This technique is a powerful new tool for generating transgenic animals for vertebrates and mammals, and a potential new vehicle for human gene therapy. Although piggyBac inserts itself randomly into the DNA, it most often locates in genes, making it useful for mutating genes and thus, revealing gene functions.
"This work represents another major step forward from Tian's laboratory. It teaches us how transposons work in mammalian systems, while providing a tool for the systematic study of gene function throughout the human and mouse genomes."
In three months, the two graduate students who worked on the project generated mice mutating 75 different genes. Xu, Min Han, an HHMI investigator at the University of Colorado, Boulder, and Yuan Zhuang of Duke University, and their colleagues at Fudan University are in the process of scaling up piggyBac for the Mouse Functional Genome Project, which is aiming to mutate the majority of mouse genes at a state-of-the-art research facility in China to systematically understand the functions of the mammalian genes.
Xu expects the technique to be particularly useful for identifying genes and drug targets for diseases such as cancers and diabetes.
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
